Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. It was health care. And shares of U.S. pharmaceutical companies promptly fell, dropping by an average range of about 3% to 5%. “We’ve got to get our drug industry back,”
The first presidential debate between Hillary Clinton and Donald Trump is scheduled for Sept. 26. The secret to success in investing and trading is to prepare for various scenarios in advance, in this case, the debate. Let us start by looking at key S&P 500 — represented by the SPDR
This post was just published on ZYX Buy Change Alert. BPMC is long from $19.20. As of this writing it is trading at $31.59. Profits have been taken as high as $32.73. 30% of the full core position size is being held. Consider protective stops, 10% tranche each in the following
This post was just published on ZYX Buy Change Alert. BPMC is a recent biotech IPO that was bought in the after market at an average price of $19.20. As of this writing it is trading at $29.20. 40% of the full core position size is being held. Consider taking profits on a
This post was just published on ZYX Buy Change Alert. In view of overall market conditions, especially the negative money flow in biotechs, consider accumulating a maximum of 40% of BPMC. Previous call was to accumulate up to 60%. Please adjust the quantity based on your own risk tolerance. You are
This post was just published on ZYX Buy Change Alert. BPMC is a biotech firm focused on developing cancer treatment therapies. This is a new IPO. It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high. Here is the plan: Consider buying